Modified low molecular weight cyclic peptides as mimetics of BDNF with improved potency, proteolytic stability and transmembrane passage in vitro

被引:31
作者
Fletcher, Jordan M. [1 ]
Hughes, Richard A. [1 ]
机构
[1] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia
关键词
BDNF; Neurotrophin; Agonist; Antagonist; Neurotrophic factor; p75; APPARENT DRUG PERMEABILITY; THEORETICAL PREDICTIONS; BIOLOGICAL-ACTIVITIES; NEUROTROPHIC FACTORS; CACO-2; MONOLAYERS; FATTY-ACIDS; BLOOD-BRAIN; CELL-LINE; ABSORPTION; TRANSPORT;
D O I
10.1016/j.bmc.2009.02.053
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We recently reported the development of the BDNF mimetic peptide cyclo-[dPAKKR] 1 which promotes the survival of cultured sensory neurons via a trkB independent mechanism [Fletcher, J. M.; Morton, C. M.; Zwar, R. A.; Murray, S. S.; O'Leary, P. D.; Hughes, R. A. J. Biol. Chem. 2008, 283, 33375]. In the present study we prepared a series of hydrophobically-modified analogues of 1 with an eye to improving its pharmacokinetic properties. Select members of this second generation of compounds showed improved biological activity, stability in plasma, and an ability to cross model biological membranes. Crown Copyright (c) 2009 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:2695 / 2702
页数:8
相关论文
共 40 条
[31]   MEMBRANE LIPID PHASE AS CATALYST FOR PEPTIDE RECEPTOR INTERACTIONS [J].
SARGENT, DF ;
SCHWYZER, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (16) :5774-5778
[33]   COMPARISON OF INTESTINAL PERMEABILITIES DETERMINED IN MULTIPLE IN-VITRO AND IN-SITU MODELS - RELATIONSHIP TO ABSORPTION IN HUMANS [J].
STEWART, BH ;
CHAN, OH ;
LU, RH ;
REYNER, EL ;
SCHMID, HL ;
HAMILTON, HW ;
STEINBAUGH, BA ;
TAYLOR, MD .
PHARMACEUTICAL RESEARCH, 1995, 12 (05) :693-699
[34]   Enhanced potency of human sonic hedgehog by hydrophobic modification [J].
Taylor, FR ;
Wen, DY ;
Garber, EA ;
Carmillo, AN ;
Baker, DP ;
Arduini, RM ;
Williams, KP ;
Weinreb, PH ;
Rayhorn, P ;
Hronowski, XP ;
Whitty, A ;
Day, ES ;
Boriack-Sjodin, A ;
Shapiro, RI ;
Galdes, A ;
Pepinsky, RB .
BIOCHEMISTRY, 2001, 40 (14) :4359-4371
[35]   N-terminal fatty acylated HiS-DPhe-Arg-Trp-NH2 tetrapeptides:: Influence of fatty acid chain length on potency and selectivity at the mouse melanocortin receptors and human melanocytes [J].
Todorovic, A ;
Holder, JR ;
Bauzo, RM ;
Scott, JW ;
Kavanagh, R ;
Abdel-Malek, Z ;
Haskell-Luevano, C .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (09) :3328-3336
[36]   Novel lipoamino acid- and liposaccharide-based system for peptide delivery:: Application for oral administration of tumor-selective somatostatin analogues [J].
Tóth, I ;
Malkinson, JP ;
Flinn, NS ;
Drouillat, B ;
Horváth, A ;
Érchegyi, J ;
Idei, M ;
Venetianer, A ;
Artursson, P ;
Lazorova, L ;
Szende, B ;
Kéri, G .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (19) :4010-4013
[37]   Intestinal transport of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg through a Caco-2 Bbe monolayer [J].
Vermeirssen, V ;
Deplancke, B ;
Tappenden, KA ;
Van Camp, J ;
Gaskins, HR ;
Verstraete, W .
JOURNAL OF PEPTIDE SCIENCE, 2002, 8 (03) :95-100
[38]   Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability [J].
Witt, KA ;
Gillespie, TJ ;
Huber, JD ;
Egleton, RD ;
Davis, TP .
PEPTIDES, 2001, 22 (12) :2329-2343
[39]   Determination of transport in the Caco-2 cell assay of compounds varying in lipophilicity using LC-MS: enhanced transport of Leu-enkephalin analogues [J].
Wong, AK ;
Ross, BP ;
Chan, YN ;
Artursson, P ;
Lazorova, L ;
Jones, A ;
Toth, I .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 16 (03) :113-118
[40]   In vitro trans-monolayer permeability calculations:: often forgotten assumptions [J].
Youdim, KA ;
Avdeef, A ;
Abbott, NJ .
DRUG DISCOVERY TODAY, 2003, 8 (21) :997-1003